4//SEC Filing
Seidel Ronald D. III 4
Accession 0001209191-18-043906
CIK 0001645460other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 4:49 PM ET
Size
5.3 KB
Accession
0001209191-18-043906
Insider Transaction Report
Form 4
Seidel Ronald D. III
EVP, Head of R&D
Transactions
- Award
Stock Option (right to buy)
2018-07-23+75,000→ 75,000 totalExercise: $11.54Exp: 2025-07-23→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in eight semi-annual installments beginning July 23, 2018.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001724872
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 4:49 PM ET
- Size
- 5.3 KB